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Abstract
A fully automatic workflow for Multiple Sclerosis (MS) lesion segmentation is described. Fully auto-
matic means that no user interaction is performed in any of the steps and that all parameters are fixed
for all the images processed in beforehand. Our workflow is composed of three steps: an intensity inho-
mogeneity (IIH) correction, skull-stripping and MS lesions segmentation. A validation comparing our
results with two experts is done on MS MRI datasets of 24 MS patients from two different sites.
1 Introduction
Magnetic Resonance Imaging (MRI) has been used as a biomarker for Multiple Sclerosis over the last
25 years. MRI has a high sensitivity to detect white matter lesions (WML) in MS patients. In cross-
sectional and longitudinal studies, manual or semi-automatic segmentation have been used to compute the
total lesion load (TLL) in T2-w, PD-w or T1-w (either unenhanced or gd-enhanced) MR sequences but
with the drawback that these methods are very time consuming and have large intra- and inter-operator
variability [9]. Automatic methods show great promise to reduce these variabilities and improve different
issues of the analysis of large multi-center study results.
The purpose of this paper is to describe our automatic segmentation workflow, based on a previous segmen-
tation algorithm already published [1]. This paper is structured as follows. In Sections 2 the data employed
in the evaluation is described. Then in Section 3, we present each step of the workflow focusing our descrip-
tion in the MS lesion segmentation algorithm. Finally in Section 4 we describe he results and we present
our discussion in Section 5.
2 The data
A total of 20 MRI datasets of MS patients were available, in whom we had access to the results of manual
MS lesion segmentation (training datasets), and in addition a further 24 subjects in whom we had no access
2to results of manual MS lesion segmentation (evaluation datasets). All datasets include five different MR
images for each subject: T1-w, T2-w, FLAIR, Mean Diffusivity (MD), and Fractional Anisotropy (FA).
Acquisitions were performed in two different hospitals: Children’s Hospital Boston (CHB) and University
of North Carolina (UNC). UNC MR datasets have a slice thickness of 1mm and in-plane resolution of 0.5
mm and CHB datasets have slice thickness of 1.5 mm and in-plane resolution of 0.5 mm. These initial data
have been rigidly registered to a common space and up-sampled to an isotropic resolution of 0.5 mm3 using
a B-spline interpolation, we had no access to the original MRI data. A neuroradiologist from each center
performed a manual segmentation of the MS lesions in the images. On visual inspection of the manual
lesion segmentation from the two sites there is evidence of high inter rater variability.
3 The workflow
In our workflow, we only use T1-w, T2-w and FLAIR sequences. We start with intensity image denoising,
inhomogeneity correction and skull stripping before performing the actual automatic MS lesion Segmenta-
tion. Each of those image preprocessing steps and the MS lesion segmentation algorithm itself are described
in the following.
3.1 Denoising
Image noise corrupts the image intensities and decreases the efficiency of segmentation algorithms. Noise
is usually due to several factors thus as the MR hardware or the MR sequence. Several methods have been
developed and are widely applied in the literature to denoise images [3]. However, a potential drawback of
the denoising algorithms is the smoothing of small lesions and the reduction of contrast with neighboring
normal appearing WM.
One of the assumptions that are made in many of the denoising algorithms is the spatial independence of
the noise. In the case of the data described in Section 2, the use of an interpolation method is creating some
spatial relationship among neighboring voxels, so the assumptions of most of the denoising methods are no
longer valid. Therefore, we do not apply any denoising of the datasets which were available for this study.
Ideally, denoising [3] is performed on the raw data as the very first step and thus the spatial independence
hypothesis remains valid.
3.2 Intensity Inhomogeneity Correction
Intensity non-uniformity in MR images is due to a number of causes during the acquisition of the MR data.
In principle, they are due to MR devices, such as B0- or B1-field non-uniformity, and relate to artifacts
caused by slow, non-anatomic intensity variations within the same tissue over an image domain.
An entropy-based algorithm for intensity inhomogeneity correction [10] is employed to correct the spatial
variations of intensity in the same tissue. Entropy-based methods do not make any assumption of the se-
quences type or tissue intensity, and therefore they can be applied to all kind of image sequences. In our
case, we performed IIH correction only on T1-w and FLAIR images as it was shown experimentally that T2-
w images have less inhomogeneity, and even more importantly that IIH methods could potentially degrade
the quality of T2-w images [8].
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Figure 1: Example of brain mask extraction. Top line, from left to right: T1-w, result of bet and final result. Bottom line:
T2-w and difference between both mask. On T1-w is difficult to precisely identify the external CSF space.
3.3 Skull Stripping
Skull stripping methods remove non-brain voxels from the image to simplify the following lesion seg-
mentation. There are multiple methods described in the literature and several comparison studies were
performed [12, 6]. The skull stripping method from the FSL library is employed, called bet [13], used as
previously described by Rex et al. [12] to improve its results.
This first algorithm employed is not perfect and usually leaves some non-brain voxels, mainly skull, optic
nerve or veins. To improve the brain mask by removing the skull and the veins, we include information
coming from T2-w and FLAIR images where veins and skull have low intensity. We use a 3-class model (in
T2-w: CSF,brain tissues and skull/veins; and in FLAIR: CSF/skull/veins, brain tissues and lesions) in each
sequence with a Expectation Maximization (EM) algorithm [4] to classify the voxels inside the first brain
mask. Then only the voxels that have been classified in both sequences as the class with skull and veins are
removed from the brain mask. An example can is shown in Figure 1.
3.4 MS Lesions Segmentation
Our original method is called STREM (Spatio Temporal Robust Expectation Maximization)[1], and after
introducing improvements to reduce the number of false positives, but also to apply STREM in datasets
where only single time point MRI’s are available. MS lesion segmentation is performed with a three-step
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process: 1. Robust estimation of Normal Appearing Brain Tissues (NABT) parameters, 2. Refinement of
outliers detection and 3. Application of lesion rules.
Estimation of NABT parameters
NABT image intensities are modeled with a 3-class finite multivariate Gaussian mixture [16], where each
class is associated to a different part of the brain: White Matter (WM), Grey Matter (GM) and CSF. All
the MR sequences are used to create a multidimensional feature space in order to benefit from the specific
inherent information of each sequence.
To calculate the NABT parameters we use a modified Expectation Maximization algorithm, called mEM,
based on the Trimmed Likelihood (TL) Estimator [11]. It was shown to have a monotonous convergence, at
least to a local maximum of TL, as the original Expectation Maximization (EM) algorithm. The idea is to
use exclusively in our computation of TL the n−h voxels that are closer to the model and reject the h voxels
more likely to be outliers.
T L = ∑n−hi=1 f (xν(i);Θ)
Where n is the total number of voxels, h the number of rejected voxels, xi is a vector with the intensities of
the m sequences of the voxel i, Θ the parameters of our 3-class model, f () the p.d.f. of the model and ν() is
a permutation function which orders voxels so that:
f (xν(1);Θ)≥ f (xν(2);Θ)≥ ...≥ f (xν(n);Θ)
The trimming parameter h is chosen arbitrarily with a high value, to ensure the rejection of all WML voxels
from the computation of the NABT parameters. In our workflow the parameter h is set to the 10% of the
pixels of the brain.
Refinement of outliers detection
In practice, the h rejected points actually contain some inliers that actually fit the NABT model reasonably
well. Thus, to refine the outliers detection, we compute the Mahalanobis distance between each of the n
voxels in the image and each NABT given the previously computed parameters. Considering that voxels
intensities in each NABT follows a Gaussian law, these Mahalanobis distances follow a χ2 law with m
d.o.f [1, 5]. Each voxel in the image is defined as an outlier if the Mahalanobis distance for every class is
greater than the threshold defined by the χ2 law, for a given p-value. In our workflow p-value is set to 0.4
to ensure all the lesion voxels will be taken into account although this means the existence of many false
positives at this stage.
Application of lesion rules
Outliers found with the Mahalanobis distance may be originated from other tissue compartments thanWML,
basically due to partial volumes, vessels, registration errors, noise, etc. In order to discriminate between
the WML and false positives, rules are defined with neurologists and neuroradiologists based on image
intensities from the respective MR sequences and voxel connectivity.
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Gadolinium-enhanced lesions and T2-w lesions. In this paper we focus in T2-w lesions that are, com-
pared to the normal apperaring WM, hyperintense in T2-w and FLAIR, and isointense or hypointense (e.g.
black holes) in T1-w. Hyperintense and hypointense voxels are defined by 3.0×σWM ± µWM, where σWM
and µWM are the standard deviation and the mean of the white matter respectively.
Voxel connectivity allows the use of neighboring rules instead of classifying each voxel independently. In
this case, a minimal size of MS lesion is defined [2], so detected lesions that have a size smaller than 3 mm3
are discarded. We also remove detected lesions that are contiguous to brain border or not contiguous to WM
tissue.
4 Results
Our workflow does not use any learning steps. Training datasets where not necessary for the final processing
of the test images. Yet, we processed these datasets in order to verify that our segmentation workflow could
handle these images. In those training datasets no numerical evaluation or optimization of parameters were
performed.
4.1 Evaluation measures
Four different measures have been employed in the comparison of the automatic MS lesion segmentation
with the expert manual segmentation. A normalization into a 0-100 range was performed [14].
• Volume Diff.: The volume difference captures the absolute percent volume difference to the expert
rater segmentation.
• Avg. Dist.: The average distance captures the symmetric average surface distance to the expert rater
segmentation.
• True Pos.: Number of lesions in the automatic lesion segmentation that overlaps with a lesion in the
expert segmentation divided by the number of overall lesions in the expert segmentation.
• False Pos.: Number of lesions in the automatic lesion segmentation that do not overlap with any lesion
in the manual segmentation divided by the number of overall lesions in the automatic segmentation.
In addition a STAPLE algorithm [15] has been performed with the two expert segmentation and other auto-
matic segmentation methods to compare their solutions.
4.2 Test images
The described workflow does not include any manual or semi automatic steps. All the images were processed
automatically with the same parameters. Table 4 shows the results for the test images. Average results show
that we are far from the value of 90 associated with the inter rater variability in the normalized scale [14],
but our results are independent of the center where MR acquisition was performed. An example of good
lesion segmentation is given in Figure 2
There are five datasets with scores under 70. CHB test1 Case15 was not processed because of a hu-
man error and UNC test1 Case07 T1-w is likely to have been done after Gadolinium injection. In
6Figure 2: Dataset CHB test1 Case08 : From left to right T1-w, T2-w, FLAIR and automatic segmentation results
Figure 3: Some artifacts (from left to right): CHB test1 06 T2-w and Flair, UNC test1 Case07 T1-w (we think
Gadolinium-enhancing T1-w)
UNC test1 Case10, the low contrast between lesions in the FLAIR image could cause problems in the
segmentation. We found that CHB FLAIR images usually have a drop in signal intensity in the superior
part of the brain, see Figure 3, that the IIH correction method was not able to correct. In the case of
CHB test1 Case06 and Case12 this intensity drop was large enough to alter our 3-class model giving low
segmentation results. In those two datasets we also find strong movement artifacts but, as our method makes
little use of the spatial information, these artifacts should be less critical in the performance as observed in
the results of UNC test1 Case02.
5 Discussion
We have presented our fully automatic workflow for the segmentation of MS lesions. Our objective is
to propose a method which is not based on training steps and can be used with different MR protocols
or scanners yielding reproducible results. Looking at the available datasets for this validation study we
strongly felt that the analysis of the results is not straight forward and there are several aspects that need to
be discussed and improved for new future validations studies: definition of MRI lesion, quality of datasets
and total lesion load of the patients.
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Ground Truth UNC Rater CHB Rater STAPLE
All Dataset Volume Diff. Avg. Dist. True Pos. False Pos. Volume Diff. Avg. Dist. True Pos. False Pos. Total Specificity Sensitivity PPV
[%] Score [mm] Score [%] Score [%] Score [%] Score [mm] Score [%] Score [%] Score
UNC test1 Case01 23.9 97 4.8 90 48.8 79 36.7 87 11.3 98 5.9 88 53.1 82 46.7 81 88 0.9892 0.5779 0.7154
UNC test1 Case02 32.4 95 4.2 91 52.9 82 43.1 83 91.1 87 4.4 91 36.4 72 13.8 100 88 0.9970 0.1357 0.8706
UNC test1 Case03 34.0 95 2.6 95 49.3 79 22.7 96 14.7 98 2.0 96 52.9 82 17.6 99 92 0.9912 0.7604 0.8260
UNC test1 Case04 37.1 95 3.5 93 50.0 80 46.2 82 2.4 100 2.0 96 59.3 85 56.4 75 88 0.9964 0.7203 0.9435
UNC test1 Case05 73.3 89 4.8 90 38.1 73 37.9 87 39.7 94 3.3 93 60.9 86 44.8 82 87 0.9971 0.2717 0.7924
UNC test1 Case06 41.5 94 11.9 75 37.9 73 75.0 64 161.4 76 20.4 58 62.5 87 86.1 57 73 0.9632 0.2049 0.2656
UNC test1 Case07 100.0 85 128.0 0 0.0 51 0.0 100 100.0 85 128.0 0 0.0 51 0.0 100 59 1.0000 0.0000 nan
UNC test1 Case08 26.3 96 6.8 86 38.3 73 51.4 78 20.5 97 5.7 88 83.3 99 56.8 75 87 0.9882 0.5901 0.5895
UNC test1 Case09 23.9 97 18.9 61 33.3 70 96.9 51 7.4 99 26.7 45 100.0 100 96.9 51 72 0.9944 0.1331 0.3549
UNC test1 Case10 22.0 97 13.5 72 35.0 71 74.1 65 341.1 50 19.0 61 50.0 80 88.9 56 69 0.9971 0.6439 0.8902
CHB test1 Case01 68.1 90 5.5 89 26.7 67 25.9 94 54.5 92 3.2 93 51.6 81 40.7 85 86 0.9998 0.2566 0.9737
CHB test1 Case02 26.0 96 4.1 92 59.1 85 51.7 78 68.5 90 2.7 94 68.4 90 27.6 93 90 0.9986 0.3723 0.9302
CHB test1 Case03 75.3 89 4.3 91 50.0 80 12.5 100 88.1 87 9.4 81 40.0 74 25.0 94 87 1.0000 0.2420 1.0000
CHB test1 Case04 26.9 96 14.9 69 45.5 77 81.1 60 64.9 91 16.7 66 38.9 74 75.7 64 75 0.9888 0.0632 0.2282
CHB test1 Case05 56.9 92 13.5 72 40.7 75 69.4 67 91.8 87 9.8 80 56.5 84 58.3 74 79 0.9980 0.0451 0.5451
CHB test1 Case06 98.6 86 27.7 43 2.8 53 96.7 51 98.5 86 27.5 43 4.5 54 96.7 51 58 0.9990 0.0001 0.0108
CHB test1 Case07 83.0 88 12.6 74 21.7 64 80.6 61 89.7 87 6.7 86 28.9 68 68.1 68 74 0.9959 0.0480 0.4711
CHB test1 Case08 44.4 94 2.6 95 70.4 91 28.6 92 62.8 91 3.6 93 58.8 85 7.1 100 93 0.9999 0.4187 0.9956
CHB test1 Case09 71.4 90 6.4 87 22.8 64 17.8 99 75.9 89 5.5 89 19.1 62 13.3 100 85 0.9996 0.2229 0.9732
CHB test1 Case10 50.7 93 3.3 93 68.4 90 50.0 79 75.9 89 4.3 91 55.2 83 30.8 91 89 0.9994 0.1730 0.9359
CHB test1 Case11 67.0 90 10.0 79 22.7 64 64.7 70 89.3 87 11.2 77 31.0 69 55.9 76 77 0.9977 0.0806 0.6554
CHB test1 Case12 99.7 85 19.2 60 6.0 55 57.1 75 99.7 85 19.7 60 10.3 57 61.9 72 69 0.9998 0.0018 0.4072
CHB test1 Case13 77.4 89 4.7 90 50.0 80 16.7 99 86.1 87 17.1 65 28.6 68 0.0 100 85 1.0000 0.1864 1.0000
CHB test1 Case15 100.0 85 128.0 0 0.0 51 0.0 100 100.0 85 128.0 0 0.0 51 0.0 100 59 1.0000 0.0000 nan
All Average 56.6 92 19.0 75 36.3 72 47.4 80 80.6 88 20.1 72 43.8 76 44.5 81 79 0.9954 0.2562 0.6988
All UNC 41.4 94 19.9 75 38.4 73 48.4 79 79.0 88 21.7 72 55.8 82 50.8 78 80 0.9914 0.4038 0.6942
All CHB 67.5 90 18.3 74 34.8 71 46.6 80 81.8 88 19.0 73 35.1 71 40.1 83 79 0.9983 0.1508 0.7020
Figure 4: Results for test images. For each measure the value is given in two different metric: real value in the left and
a normalized value in the right.
5.1 Definition of MS lesion in MRI
Compared to the segmentation validation of other targets, MS lesion segmentation have an increased com-
plexity. Today there is no consensus on a precise definition of MS lesion in MRI. This situation leads to
a very high variability, in first place, in the detection. In second place, and once all the lesions have been
detected, there is a still a high variability in contour of each lesion [9, 17, 7], as MS lesions not rarely lack a
sharp border, but also because MS lesion size and border vary according to the MR sequence used [7].
5.2 Quality of datasets
Quality of MR acquisition is difficult to evaluate but image artifacts complicate futher image analysis and
can decrease the detectability of the lesions. For example, UNC datasets were easier to segment as the have
less artifacts. Mixing images with and without strong artifacts also complicates the analysis of the results
as we have to distinguish between separate influences of MRI artifacts and robustness or accuracy of the
segmentation methods. For validation purposes, the MR datasets may be divided in two groups according
their acquisition: without and with strong artifacts. In addition, MR raw data should be available to allow
the use of the whole segmentation workflow, as described in Section 3.1.
5.3 Total lesion load of the MS patients
Accuracy of segmentation methods vary with the magnitude of lesion load or degree of atrophy, and should
be taken into account when interpreting our results. In addition, the measures in the validation are very
dependent on the total number of lesions: for example when there are only a few lesions missing one single
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lesion will significantly drop True Positives while when there are many lesions True Positives will only
decrease very little.
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